ZBIO Zenas BioPharma, Inc. - Common Stock
$31,18
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$14–$45
57% of range
Analystenbewertung
STRONG BUY
14 analysts
Kursziel
$44
+40% upside
P/E (TTM)
-3.7
ROE
-156.8%
Nettogewinnmarge
-3777.4%
ZBIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$31.18
Marktkapitalisierung
$1.70B
P/E (TTM)
-3.7
EPS (TTM)
$-8.44
Umsatz (TTM)
$10M
Dividendenrendite
—
ROE
-156.8%
Verschuldungsgrad
0.3
52W-Spanne
$14 – $45
ZBIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$10M
2023-12-31
→
2025-12-31
EPS
$-8.44
2023-12-31
→
2025-12-31
Freier Cashflow
$-172M
2024-12-31
→
2025-12-31
Margen
-3777.4%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ZBIO
Peer-Median
P/E (TTM)
-3.7
27.2
P/S (TTM) (K/V (TTM))
169.9
25.4
P/B (K/B)
7.0
5.1
EV / EBITDA
-3.7
—
Price / FCF (Kurs / FCF)
-9.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ZBIO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-3830.6%
—
Net Profit Margin (Nettogewinnmarge)
-3777.4%
-473.7%
ROA
-100.2%
-40.2%
ROE
-156.8%
-50.4%
ROIC
-119.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ZBIO
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.3
—
Current Ratio (Liquiditätsgrad)
5.6
9.0
Quick Ratio
5.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ZBIO
Peer-Median
Revenue YoY (Umsatz YoY)
100.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ZBIO
Peer-Median
ZBIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 7 50,0%
- Kauf 5 35,7%
- Halten 2 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-15
Median
$44.50
Jetzt
$31.18
Tief
$22.00
Hoch
$59.00
Median-Ziel
$44.50
+42,7%
Mittelwert-Ziel
$43.50
+39,5%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-1.1%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-1.46 | $-1.62 | 0.16% |
| 31. Dezember 2025 | $-4.54 | $-1.05 | -3.5% |
| 30. September 2025 | $-1.22 | $-1.07 | -0.15% |
| 30. Juni 2025 | $-1.25 | $-1.07 | -0.18% |
| 31. März 2025 | $-0.80 | $-1.13 | 0.33% |
| 31. Dezember 2024 | $-3.99 | $-1.02 | -3.0% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| GENB | — | — | — | — | — | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $10M | $5M | $50M | |
| R&D Expense | $168M | $139M | $60M | |
| SG&A Expense | $53M | $30M | $17M | |
| Operating Expenses | $393M | $169M | $87M | |
| Operating Income | $-383M | $-164M | $-37M | |
| Interest Income | $12M | $8M | · | |
| Other Non-op | $417.0K | $202.0K | $624.0K | |
| Pretax Income | $-378M | $-157M | $-37M | |
| Income Tax | $-79.0K | $429.0K | $301.0K | |
| Net Income | $-378M | $-157M | $-37M | |
| EPS (Basic) | $-8.44 | $-11.89 | $-24.25 | |
| EPS (Diluted) | $-8.44 | $-11.89 | $-24.25 | |
| Shares (Basic) | 44,730,052 | 13,198,960 | 1,531,178 | |
| Shares (Diluted) | 44,730,052 | 13,198,960 | 1,531,178 | |
| EBITDA | $-383M | $-164M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $111M | $320M | $57M | |
| Short-term Investments | $233M | $31M | · | |
| Prepaid Expense | $8M | $5M | $3M | |
| Current Assets | $351M | $356M | $60M | |
| PP&E (Net) | $34.0K | $185.0K | $193.0K | |
| Other Non-current Assets | $14M | $13M | $7M | |
| Total Assets | $384M | $370M | $68M | |
| Accounts Payable | $7M | $17M | $5M | |
| Accrued Liabilities | $54M | $39M | $17M | |
| Current Liabilities | $63M | $57M | $23M | |
| Capital Leases | $211.0K | $218.0K | $257.0K | |
| Total Liabilities | $141M | $58M | $44M | |
| Total Debt | $79M | · | · | |
| Common Stock | $5.0K | $4.0K | · | |
| Paid-in Capital | $1.01B | $700M | $5M | |
| Retained Earnings | $-765M | $-387M | $-230M | |
| AOCI | $-64.0K | $194.0K | $37.0K | |
| Stockholders' Equity | $242M | $312M | $-226M | |
| Liabilities + Equity | $384M | $370M | $68M | |
| Shares Outstanding | 54,485,518 | 41,793,412 | 1,576,854 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $26M | $11M | $3M | |
| Operating Cash Flow | $-172M | $-120M | $-31M | |
| CapEx | $18.0K | $131.0K | $17.0K | |
| Investing Cash Flow | $-252M | $-31M | $-17.0K | |
| Financing Cash Flow | $215M | $413M | $20M | |
| Net Change in Cash | $-209M | $263M | $-10M | |
| Taxes Paid | $15.0K | · | · | |
| Free Cash Flow | $-172M | $-120M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -3830.6% | -3277.8% | · | |
| Net Margin | -3777.4% | -3139.8% | · | |
| Pretax Margin | -3778.2% | -3131.2% | · | |
| EBITDA Margin | -3830.6% | -3277.8% | · | |
| ROA | -100.2% | -71.7% | · | |
| ROE | -156.8% | -46.7% | · | |
| ROIC | -119.4% | -52.6% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 5.6 | 6.2 | · | |
| Quick Ratio | 5.5 | 6.1 | · | |
| Debt / Equity | 0.3 | · | · | |
| LT Debt / Equity | 0.3 | · | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 100.0% | -90.0% | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $10M | $5M | · | |
| Net Income TTM | $-378M | $-157M | · | |
| Market Cap | $1.98B | $342M | · | |
| Enterprise Value | $1.71B | · | · | |
| P/E | -4.3 | -0.7 | · | |
| P/S | 197.8 | 68.5 | · | |
| P/B | 8.2 | 1.1 | · | |
| P / Tangible Book | 8.2 | 1.1 | · | |
| P / Cash Flow | -11.5 | -2.9 | · | |
| P / FCF | -11.5 | -2.9 | · | |
| EV / EBITDA | -4.5 | · | · | |
| EV / FCF | -9.9 | · | · | |
| EV / Revenue | 171.4 | · | · | |
| Earnings Yield | -23.2% | -145.2% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | · | $0 | $0 | $0 | $10M | $5M | $0 | $0 | · | $0 | |
| R&D Expense | $63M | $60M | $56M | $34M | $43M | $35M | $49M | $34M | $34M | $23M | $20M | |
| SG&A Expense | $16M | $17M | $16M | $13M | $12M | $12M | $11M | $7M | $6M | $5M | $4M | |
| Operating Expenses | $109M | $77M | $238M | $53M | $55M | $47M | $61M | $41M | $40M | $28M | $25M | |
| Operating Income | $-108M | $-77M | $-238M | $-53M | $-55M | $-37M | $-56M | $-41M | $-40M | $-28M | $-25M | |
| Interest Income | $7M | $3M | · | · | $3M | $3M | · | · | · | · | · | |
| Other Non-op | $16.0K | $-24.0K | $-7M | $1M | $217.0K | $158.0K | $-5M | $2M | $2M | $472.0K | $793.0K | |
| Pretax Income | $-111M | $-81M | $-240M | $-51M | $-52M | $-34M | $-52M | $-39M | $-38M | $-28M | · | |
| Income Tax | $114.0K | · | $106.0K | $0 | $20.0K | $-205.0K | · | · | · | · | · | |
| Net Income | $-111M | $-81M | $-240M | $-51M | $-52M | $-34M | $-53M | $-39M | $-38M | $-28M | $-25M | |
| EPS (Basic) | $-1.77 | $-1.46 | $-5.17 | $-1.22 | $-1.25 | $-0.80 | $35.25 | $-5.02 | $-24.23 | $-17.89 | $-16.04 | |
| EPS (Diluted) | $-1.77 | $-1.46 | $-5.17 | $-1.22 | $-1.25 | $-0.80 | $35.25 | $-5.02 | $-24.23 | $-17.89 | $-16.04 | |
| Shares (Basic) | 63,112,314 | 55,624,631 | -81,095,490 | 42,159,340 | 41,865,400 | 41,800,802 | 2,379,909 | 7,697,695 | 1,567,269 | 1,554,087 | 3,448 | |
| Shares (Diluted) | 63,112,314 | 55,624,631 | -81,095,490 | 42,159,340 | 41,865,400 | 41,800,802 | 2,379,909 | 7,697,695 | 1,567,269 | 1,554,087 | 3,448 | |
| EBITDA | $-108M | $-77M | · | $-53M | $-55M | $-37M | · | $-41M | · | · | · |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $197M | $500M | $111M | $116M | $44M | $197M | $320M | $360M | · | · | $57M | |
| Short-term Investments | $447M | $217M | $233M | $175M | $229M | $116M | $31M | $27M | · | · | · | |
| Prepaid Expense | $11M | $13M | $8M | $6M | $5M | $5M | $5M | $7M | · | · | $3M | |
| Current Assets | $654M | $730M | $351M | $297M | $279M | $318M | $356M | $394M | · | · | $60M | |
| PP&E (Net) | $23.0K | $28.0K | $34.0K | $50.0K | $61.0K | $72.0K | $185.0K | $146.0K | · | · | $193.0K | |
| Other Non-current Assets | $16M | $15M | $14M | $14M | $12M | $13M | $13M | $9M | · | · | $7M | |
| Total Assets | $702M | $748M | $384M | $322M | $293M | $334M | $370M | $403M | · | · | $68M | |
| Accounts Payable | $8M | $9M | $7M | $6M | $8M | $20M | $17M | $15M | · | · | $5M | |
| Accrued Liabilities | $57M | $51M | $54M | $45M | $45M | $28M | $39M | $29M | · | · | $17M | |
| Current Liabilities | $66M | $61M | $63M | $52M | $53M | $49M | $57M | $44M | · | · | $23M | |
| Capital Leases | $22.0K | $77.0K | $211.0K | $180.0K | $215.0K | $317.0K | $218.0K | · | · | · | $257.0K | |
| Total Liabilities | $455M | $412M | $141M | $126M | $53M | $49M | $58M | $44M | · | · | $44M | |
| Total Debt | · | · | · | $73M | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | · | · | |
| Paid-in Capital | $1.21B | $1.18B | $1.01B | $721M | $713M | $705M | $700M | $694M | · | · | $5M | |
| Retained Earnings | $-958M | $-846M | $-765M | $-525M | $-473M | $-421M | $-387M | $-335M | · | · | $-230M | |
| AOCI | $-1M | $-377.0K | $-64.0K | $-69.0K | $-94.0K | $141.0K | $194.0K | $54.0K | · | · | $37.0K | |
| Stockholders' Equity | $247M | $336M | $242M | $196M | $240M | $284M | $312M | $359M | · | · | $-226M | |
| Liabilities + Equity | $702M | $748M | $384M | $322M | $293M | $334M | $370M | $403M | · | · | $68M | |
| Shares Outstanding | 63,330,747 | 62,383,377 | 54,485,518 | 42,213,465 | 42,088,697 | 41,821,887 | 41,793,412 | 41,780,938 | · | · | 1,576,854 |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $8M | $7M | $6M | $5M | $5M | $3M | $2M | $947.0K | $1M | |
| Operating Cash Flow | $-57M | $-75M | $-52M | $-41M | $-42M | $-37M | $-39M | $-31M | $-31M | $-19M | $-15M | |
| CapEx | $0 | $2.0K | $0 | $0 | $0 | $18.0K | $74.0K | $0 | $35.0K | $22.0K | · | |
| Investing Cash Flow | $-288M | $32M | $-93M | $40M | $-112M | $-86M | $-4M | $-27M | $-35.0K | $-22.0K | · | |
| Financing Cash Flow | $42M | $433M | $141M | $73M | $2M | $99.0K | $2M | $234M | $178M | $-614.0K | $50.0K | |
| Net Change in Cash | $-304M | $390M | $-5M | $72M | $-153M | $-123M | $-40M | $176M | $147M | $-20M | $-15M | |
| Free Cash Flow | · | $-75M | · | · | · | $-37M | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10765.9% | · | · | · | · | -373.3% | · | · | · | · | · | |
| Net Margin | -11145.6% | · | · | · | · | -335.7% | · | · | · | · | · | |
| Pretax Margin | -11134.2% | · | · | · | · | -337.8% | · | · | · | · | · | |
| EBITDA Margin | -10765.9% | · | · | · | · | -373.3% | · | · | · | · | · | |
| ROA | -22.4% | -15.0% | · | -14.2% | -35.6% | -20.1% | · | -19.1% | · | · | · | |
| ROE | -45.8% | -26.1% | · | -18.5% | -43.6% | -23.6% | · | -21.5% | · | · | · | |
| ROIC | -43.6% | · | · | · | -23.0% | -13.1% | · | · | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 11.9 | · | 5.7 | 5.2 | 6.5 | · | 9.0 | · | · | · | |
| Quick Ratio | 9.8 | 11.7 | · | 5.5 | 5.1 | 6.4 | · | 8.8 | · | · | · | |
| Debt / Equity | · | · | · | 0.4 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.4 | · | · | · | · | · | · | · |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.1 | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $10M | · | $10M | $10M | · | · | · | · | · | · | |
| Net Income TTM | $-296M | $-218M | · | $-176M | $-162M | $-138M | · | $-69M | · | · | · | |
| Market Cap | $1.61B | $1.22B | · | $937M | $408M | $330M | · | $707M | · | · | · | |
| Enterprise Value | · | · | · | $719M | · | · | · | · | · | · | · | |
| P/E | -4.5 | -4.1 | · | -2.7 | -0.3 | -0.2 | · | -0.4 | · | · | · | |
| P/S | · | 122.0 | · | 93.7 | 40.8 | · | · | · | · | · | · | |
| P/B | 6.5 | 3.6 | · | 4.8 | 1.7 | 1.2 | · | 2.0 | · | · | · | |
| P / Tangible Book | 6.5 | 3.6 | · | 4.8 | 1.7 | 1.2 | · | 2.0 | · | · | · | |
| P / Cash Flow | · | -16.2 | · | · | · | -8.9 | · | · | · | · | · | |
| P / FCF | · | -16.2 | · | · | · | -8.9 | · | · | · | · | · | |
| EV / EBITDA | · | · | · | -13.7 | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 71.9 | · | · | · | · | · | · | · | |
| Earnings Yield | -22.5% | -24.2% | · | -37.3% | -323.0% | -606.8% | · | -267.0% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $10M | $5M | $50M |
| Betriebsgewinnmarge % | -3830.6% | -3277.8% | — |
| Nettoergebnis | $-378M | $-157M | $-37M |
| Verwässerte EPS | $-8.44 | $-11.89 | $-24.25 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | — | — |
| Liquiditätsgrad | 5.6 | 6.2 | — |
| Quick Ratio | 5.5 | 6.1 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-172M | $-120M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 152 Einreicher · $1.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 35 (-11 vs. Vorquartal) | 21 (-13 vs. Vorquartal) | 61 (+1 vs. Vorquartal) | 36 (+19 vs. Vorquartal) | +7.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $189.573.930 | 7.469.422 | 14,77% | Aktien |
| SR One Capital Management, LP | $127.860.735 | 5.037.854 | 9,96% | Aktien |
| NEA Management Company, LLC | $102.109.298 | 4.023.219 | 7,95% | Aktien |
| ENAVATE SCIENCES GP, LLC | $99.468.255 | 3.919.159 | 7,75% | Aktien |
| FEDERATED HERMES, INC. | $79.104.511 | 3.116.805 | 6,16% | Aktien |
| Capital International Investors | $63.523.907 | 2.502.912 | 4,95% | Aktien |
| Polar Capital Holdings Plc | $61.236.153 | 2.412.772 | 4,77% | Aktien |
| Fairmount Funds Management LLC | $59.872.055 | 2.359.025 | 4,66% | Aktien |
| STATE STREET CORP | $52.158.438 | 2.055.100 | 4,06% | Aktien |
| NVP ASSOCIATES, LLC | $46.660.673 | 1.838.482 | 3,63% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $34.386.448 | 1.354.864 | 2,68% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $32.046.159 | 1.262.654 | 2,50% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $21.571.235 | 1.103.388 | 1,68% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $20.688.507 | 815.150 | 1,61% | Aktien |
| EcoR1 Capital, LLC | $20.037.510 | 789.500 | 1,56% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $19.157.734 | 754.651 | 1,49% | Aktien |
| BANK OF AMERICA CORP /DE/ | $17.914.016 | 705.832 | 1,40% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $16.762.729 | 660.470 | 1,31% | Aktien |
| Woodline Partners LP | $14.987.880 | 590.539 | 1,17% | Aktien |
| Balyasny Asset Management L.P. | $14.637.077 | 576.717 | 1,14% | Aktien |
| ArrowMark Colorado Holdings LLC | $14.550.811 | 573.318 | 1,13% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $12.938.445 | 509.789 | 1,01% | Aktien |
| Rock Springs Capital Management LP | $12.742.714 | 502.077 | 0,99% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $12.455.641 | 490.766 | 0,97% | Aktien |
| NEXTBio Capital Management LP | $10.830.560 | 426.736 | 0,84% | Aktien |
| Vestal Point Capital, LP | $9.263.700 | 365.000 | 0,72% | Aktien |
| JENNISON ASSOCIATES LLC | $7.970.564 | 314.049 | 0,62% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.737.601 | 304.870 | 0,60% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.666.917 | 302.085 | 0,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.462.332 | 254.623 | 0,50% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $5.858.567 | 230.834 | 0,46% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.740.956 | 226.200 | 0,45% | Kaufoption |
| Walleye Capital LLC | $5.305.689 | 209.050 | 0,41% | Aktien |
| Sio Capital Management, LLC | $5.293.177 | 208.557 | 0,41% | Aktien |
| Voleon Capital Management LP | $4.242.140 | 167.145 | 0,33% | Aktien |
| CITADEL ADVISORS LLC | $4.231.024 | 166.707 | 0,33% | Aktien |
| UBS Group AG | $4.150.239 | 163.524 | 0,32% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $3.834.563 | 151.086 | 0,30% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.814.842 | 150.309 | 0,30% | Aktien |
| Squarepoint Ops LLC | $3.177.195 | 125.185 | 0,25% | Aktien |
| BARCLAYS PLC | $2.858.652 | 112.634 | 0,22% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $2.538.000 | 100.000 | 0,20% | Aktien |
| Birchview Capital, LP | $2.375.593 | 93.601 | 0,19% | Aktien |
| Verition Fund Management LLC | $1.852.435 | 72.988 | 0,14% | Aktien |
| J. Goldman & Co LP | $1.731.728 | 68.232 | 0,13% | Aktien |
| ALPS ADVISORS INC | $1.616.072 | 63.675 | 0,13% | Aktien |
| Swiss National Bank | $1.350.216 | 53.200 | 0,11% | Aktien |
| Exome Asset Management LLC | $1.331.003 | 52.443 | 0,10% | Aktien |
| Jump Financial, LLC | $1.294.939 | 51.022 | 0,10% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.230.042 | 48.465 | 0,10% | Aktien |
| CITIGROUP INC | $1.215.118 | 47.877 | 0,09% | Aktien |
| XTX Topco Ltd | $1.016.063 | 40.034 | 0,08% | Aktien |
| Burkehill Global Management, LP | $1.015.200 | 40.000 | 0,08% | Aktien |
| JANE STREET GROUP, LLC | $989.820 | 39.000 | 0,08% | Kaufoption |
| Rafferty Asset Management, LLC | $951.978 | 37.509 | 0,07% | Aktien |
| Atom Investors LP | $942.842 | 37.149 | 0,07% | Aktien |
| RHUMBLINE ADVISERS | $869.128 | 34.245 | 0,07% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $844.646 | 33.280 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $784.242 | 30.900 | 0,06% | Kaufoption |
| DCF Advisers, LLC | $715.310 | 28.184 | 0,06% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $683.280 | 26.922 | 0,05% | Aktien |
| WELLS FARGO & COMPANY/MN | $659.753 | 25.995 | 0,05% | Aktien |
| MARSHALL WACE, LLP | $597.978 | 23.561 | 0,05% | Aktien |
| BlackRock, Inc. | $580.364 | 22.867 | 0,05% | Aktien |
| VANGUARD GROUP INC | $535.500 | 14.748 | 0,04% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $523.412 | 20.623 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $479.682 | 18.900 | 0,04% | Verkaufsoption |
| China Universal Asset Management Co., Ltd. | $478.362 | 18.848 | 0,04% | Aktien |
| PROFUND ADVISORS LLC | $478.108 | 18.838 | 0,04% | Aktien |
| ALLSTATE CORP | $462.957 | 18.241 | 0,04% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $439.886 | 17.332 | 0,03% | Aktien |
| MetLife Investment Management, LLC | $432.501 | 17.041 | 0,03% | Aktien |
| Virtus Investment Advisers, LLC | $419.405 | 16.525 | 0,03% | Aktien |
| Bank of New York Mellon Corp | $418.592 | 16.493 | 0,03% | Aktien |
| Point72 Asset Management, L.P. | $409.532 | 16.136 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $389.126 | 15.332 | 0,03% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $382.872 | 15.050 | 0,03% | Aktien |
| Brevan Howard Capital Management LP | $372.426 | 14.674 | 0,03% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $331.615 | 13.066 | 0,03% | Aktien |
| Engineers Gate Manager LP | $329.432 | 12.980 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $323.341 | 12.740 | 0,03% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $309.261 | 15.819 | 0,02% | Aktien |
| Invesco Ltd. | $286.337 | 11.282 | 0,02% | Aktien |
| VARCOV Co. | $266.617 | 10.505 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $261.414 | 10.300 | 0,02% | Aktien |
| JPMORGAN CHASE & CO | $245.152 | 8.188 | 0,02% | Aktien |
| Scientech Research LLC | $229.131 | 9.028 | 0,02% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $225.222 | 8.874 | 0,02% | Aktien |
| Quantinno Capital Management LP | $217.786 | 8.581 | 0,02% | Aktien |
| State of New Jersey Common Pension Fund D | $217.532 | 8.571 | 0,02% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $213.649 | 8.418 | 0,02% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $203.852 | 8.032 | 0,02% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $191.949 | 7.563 | 0,01% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $191.086 | 7.529 | 0,01% | Aktien |
| Nuveen Asset Management, LLC | $163.055 | 19.909 | 0,01% | Aktien |
| KLP KAPITALFORVALTNING AS | $154.818 | 6.100 | 0,01% | Aktien |
| PNC Financial Services Group, Inc. | $114.845 | 4.525 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $113.601 | 4.476 | 0,01% | Aktien |
| Vanguard Investments Australia, Ltd. | $106.571 | 4.199 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $71.673 | 2.824 | 0,01% | Aktien |
Unternehmensinsider 13 Insider · 5 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| MOULDER LEON O JR | Chief Executive Officer | 15. Juni 2026 A | 96.928 | 10 | 0 | $6.533.809 |
| Jennifer A. Fox | Chief Business Officer and Chief Financial Officer | 15. Juni 2026 A | 1.592 | 0 | 0 | $0 |
| Joseph L Farmer | President and Chief Operating Officer | 15. Juni 2026 A | 974 | 0 | 0 | $0 |
| Lisa Von Moltke | Head of Research and Development and Chief Medical Officer | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Orlando Oliveira | Chief Commercial Officer | 10. Juni 2025 A | — | 0 | 0 | $0 |
| James P Boylan | Direktor | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Hongbo Lu | Direktor | 15. Juni 2026 A | 426.736 | 5 | 0 | $8.154.891 |
| John J Orloff | Direktor | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Jason Raleigh Nunn | Direktor | 15. Juni 2026 A | 1.173.395 | 1 | 0 | $1.200.002 |
| Patricia L Allen | Direktor | 15. Juni 2026 A | 19.860 | 4 | 0 | $499.746 |
| Patrick G. Enright | Direktor | 15. Juni 2026 A | 11.990 | 2 | 0 | $2.250.027 |
| Ting Xiao | Direktor | 7. Februar 2025 P | 10.000 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10%-Eigentümer | 16. September 2024 C | 801.624 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| SR One Capital Management, LLC, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, AMZL, LP, SR One Capital SMA Partners, LP, SR One Capital Opportunities Fund I, LP, SR One Capital Opportunities Partners I, LP, Simeon George ×3 Einreichungen | 17. August 2026 | 7,70% | Änderung | — | SEC |
| MOULDER LEON O JR, Tellus BioVentures, LLC, Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 ×5 Einreichungen | 5. Mai 2026 | 5,09% | Erste Einreichung | Passive Anlage | SEC |
| Enavate Sciences GP, LLC, Zebra Aggregator, LP ×2 Einreichungen | 14. Oktober 2025 | 7,30% | Änderung | — | SEC |
| Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×2 Einreichungen | 14. Oktober 2025 | 4,90% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 36 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,63% | 55.332 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,44% | 9.817 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,35% | 6.799 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 96.703 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,19% | 51.847 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,14% | 3.433 SH | 8. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,09% | 56.997 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,08% | 235.244 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,06% | 261.112 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,05% | 1.983 NS | 31. Mai 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,05% | 24.662 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 27.907 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 30.536 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,03% | 6.636 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 729.732 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 15.596 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 9.928 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 164.002 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,02% | 1.340 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 10.171 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.108 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 134.982 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 435.390 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 79.801 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 1.963 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 865 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 7.339 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 874 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 16.937 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 58.988 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 22 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 595 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4.711 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 16.334 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 891.196 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.624 SH | 8. August 2026 | Täglich |